The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury - Wikidata - wikimedia - TriplyDB

The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury

The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury

http://www.wikidata.org/entity/Q33603645

about

RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism Role of hemostatic factors in hepatic injury and disease: animal models de-liver.Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.Plasminogen Activator Inhibitor-1 Reduces tPA-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

P2860

Q36944655-C24A0FFC-B73A-4578-9B0D-CE61C579DC90 Q36965875-4702F907-EAB9-4603-824B-39BD2AE8E442 Q37387653-0FF139D7-2D6D-4E7C-A36D-D87781C4E16B Q37387670-7BF3D160-3110-42D4-9543-DA7CDFC3142B Q37681886-F8CCE605-2E8A-4D77-91F7-3DA75448CC9E Q47147995-B075E8D3-4B71-4597-AFA4-9B75E3B0F692 Q49897021-587F1CCE-9638-49F2-8C58-C8E2B360BA76 Q50142593-282FC4A1-DA28-468B-AC74-A63D87C4AB8E

P2860

The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury

http://www.wikidata.org/entity/Q33603645

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@ast

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@en

type

label

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@ast

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@en

prefLabel

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@ast

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@en

P1433

Q33603645-DA52C507-D089-405A-97CE-D867A61BF966

P1476

Q33603645-6F666B3E-9614-4B4F-B1ED-0D2D67CBD57A

P2093

Q33603645-1DADF291-42C7-48D8-80BD-FDBFABC2687E

Q33603645-B73275C1-B05C-4100-97D6-BE7F60401E15

Q33603645-DA2D6863-C572-4E45-8BEC-CC4B523965B7

Q33603645-F732315B-054D-419F-B90E-FD9F39490E0E

P2860

Q33603645-01FC5AD2-1DFE-4458-97F1-1B94C24D3D5C

Q33603645-1B4EB5B2-9637-49A4-A4F6-446BED344334

Q33603645-205CBE19-AE0E-495D-BBDC-00C5758F0EE7

Q33603645-22143336-C816-4D84-A585-45D66B116A94

Q33603645-22173861-9EA7-464B-ADEC-21DEE1F74349

Q33603645-2446FB70-6DE4-4996-B891-A175B5630F73

Q33603645-301A9315-09F1-4419-A851-C629A7285289

Q33603645-30A77C35-0B09-4374-B9B2-24A5B7E23EAF

Q33603645-31A5747A-DD15-4655-8587-EBC6F2962E55

Q33603645-39D7EA77-7FEA-4DC5-800B-E7B3D6C3C2C2

P304

Q33603645-D18E69BA-6230-4A51-B07B-FEC64BF03AB5

P31

Q33603645-272CF46E-0E48-4677-964A-EB0A7F8A8829

P356

Q33603645-FCD000BD-3FA0-4973-876B-9B5C6BDE62CA

P407

Q33603645-545D51B5-1420-4FD1-96CD-FC474871F034

P433

Q33603645-0BE5BEB2-4B9C-47E2-9819-674C18FE5694

P478

Q33603645-599CBFDC-6C0F-4200-9D2C-F376D0DBD798

P50

Q33603645-3344FF1F-B4D6-4435-8A49-C4ECA28448A7

P577

Q33603645-1153E17C-B01B-4494-AB10-A6933F85432C

P5875

Q33603645-8E601AC3-E667-4D64-9E3F-FF97AF8DBD20

P698

Q33603645-46C59EBC-E486-48A8-833C-0DB3D5F8274C

P932

Q33603645-B7C31399-3ED9-47BE-86C5-925F5376DAC1

P356

JPET.113.210880

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

The antifibrinolytic drug tran ...... el of chronic bile duct injury

@en

P2093

Anna K Kopec

http://www.w3.org/2001/XMLSchema#string

James P Luyendyk

http://www.w3.org/2001/XMLSchema#string

Keara Towery

http://www.w3.org/2001/XMLSchema#string

Kurt J Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver

Plasminogen activators direct reorganization of the liver lobule after acute injury

Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis

Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury

Tranexamic acid: a review of its use in surgery and other indications.

PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

Role of alphavbeta6 integrin in acute biliary fibrosis

The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.

P304

383-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.113.210880

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260842268

http://www.w3.org/2001/XMLSchema#string

P698

24633426

http://www.w3.org/2001/XMLSchema#string

P932

4019324

http://www.w3.org/2001/XMLSchema#string